Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    October 2020
  1. REGINA SM, Maria L, Reinhold F, Elisabeth S, et al
    Rapid Switch from Subcutaneous to Intravenous Treprostinil in Precapillary Pulmonary Hypertension by Pump Implantation.
    J Cardiovasc Pharmacol. 2020 Oct 15. doi: 10.1097/FJC.0000000000000933.
    PubMed     Abstract available


  2. DE JESUS SILVA F, Drummond FR, Fidelis MR, Freitas MO, et al
    Continuous aerobic exercise prevents detrimental remodeling and right heart myocyte contraction and calcium cycling dysfunction in pulmonary artery hypertension.
    J Cardiovasc Pharmacol. 2020 Oct 9. doi: 10.1097/FJC.0000000000000928.
    PubMed     Abstract available


    June 2020
  3. TANG M, Wang R, Feng P, Dong Q, et al
    Dihydroartemisinin Attenuates Pulmonary Hypertension via Inhibition of Pulmonary Vascular Remodeling in Rats.
    J Cardiovasc Pharmacol. 2020 Jun 5. doi: 10.1097/FJC.0000000000000862.
    PubMed     Abstract available


  4. GAO X, Zhang Z, Li X, Wei Q, et al
    Ursolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism.
    J Cardiovasc Pharmacol. 2020;75:545-555.
    PubMed     Abstract available


    May 2020
  5. GRZESK G, Karasek D, Kusiak M
    Thrombocytopenia During Prostacyclin Analogue Therapies of Pulmonary Arterial Hypertension-Possible Pathomechanisms and Implications.
    J Cardiovasc Pharmacol. 2020;75:421-425.
    PubMed     Abstract available


    April 2020
  6. HOPPER RK, Ivy DD, Yung D, Mullen MP, et al
    Pharmacokinetics of Oral Treprostinil in Children with Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2020 Apr 16. doi: 10.1097/FJC.0000000000000842.
    PubMed     Abstract available


    March 2020
  7. DONG F, Zhang J, Chen X, Zhang S, et al
    Chrysin Alleviates Monocrotaline-induced Pulmonary Hypertension (MCTPH) in Rats via Regulation of Intracellular Calcium Homeostasis in pulmonary arterial smooth muscle cells (PASMCs).
    J Cardiovasc Pharmacol. 2020 Mar 9. doi: 10.1097/FJC.0000000000000823.
    PubMed     Abstract available


  8. GAVOTTO A, Thomas F, Werner O, Moreau J, et al
    Use of treprostinil in pediatric pulmonary hypertension: case reports and review of the literature.
    J Cardiovasc Pharmacol. 2020 Mar 9. doi: 10.1097/FJC.0000000000000820.
    PubMed     Abstract available


    January 2020
  9. PARIKH KS, Doerfler S, Shelburne N, Kennedy K, et al
    Experience in Transitioning from Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2020 Jan 13. doi: 10.1097/FJC.0000000000000800.
    PubMed     Abstract available


    November 2019
  10. DONG F, Zhang J, Zhu S, Lan T, et al
    Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.
    J Cardiovasc Pharmacol. 2019;74:426-435.
    PubMed     Abstract available


    February 2018
  11. ABID S, Kebe K, Houssaini A, Tomberli F, et al
    New NO Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
    J Cardiovasc Pharmacol. 2018 Feb 8. doi: 10.1097/FJC.0000000000000570.
    PubMed     Abstract available


    June 2017
  12. HANSEN MS, Andersen A, Holmboe S, Schultz JG, et al
    Levosimendan prevents and reverts right ventricular failure in experimental pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2017 Jun 19. doi: 10.1097/FJC.0000000000000508.
    PubMed     Abstract available


    October 2016
  13. CAMPOS C, Luz de Castro A, Vicente Tavares AM, Fernandes RO, et al
    Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Abstract available


    February 2016
  14. FARES WH
    Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What's Reasonable?
    J Cardiovasc Pharmacol. 2016.
    PubMed    


    January 2016
  15. PARIKH KS, Rajagopal S, Fortin T, Tapson VF, et al
    Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Abstract available


  16. LI Y, Geng X, Wang H, Cheng G, et al
    CTRP9 ameliorates pulmonary-arterial hypertension through attenuating inflammation and improving endothelial cell survival and function.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Abstract available


  17. AKAGI S, Nakamura K, Matsubara H, Kondo M, et al
    Intratracheal administration of prostacyclin analog-incorporated nanoparticles ameliorates the development of monocrotaline and sugen/hypoxia-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Abstract available


    December 2015
  18. SHANG P, He ZY, Chen JF, Huang SY, et al
    Absence of the Adenosine A2A Receptor Confers Pulmonary Arterial Hypertension Through RhoA/ROCK Signaling Pathway in Mice.
    J Cardiovasc Pharmacol. 2015;66:569-75.
    PubMed     Abstract available


    November 2015
  19. ZHENG Y, Ma H, Hu E, Huang Z, et al
    Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
    J Cardiovasc Pharmacol. 2015;66:504-14.
    PubMed     Abstract available


    October 2015
  20. FANG X, Chen X, Zhong G, Chen Q, et al
    Mitofusin 2 downregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PI3K/Akt and mitochondrial apoptosis pathways.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Abstract available


  21. LI MX, Jiang DQ, Wang Y, Chen QZ, et al
    Signal mechanisms of vascular remodeling in the development of pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Abstract available


    June 2015
  22. WANG K, Ma J, Pang Y, Lao J, et al
    Niflumic acid attenuated pulmonary artery tone and vascular structural remodeling of pulmonary arterial hypertension induced by high pulmonary blood flow in vivo.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Abstract available


    April 2015
  23. DAMY T, Hobkirk J, Walters M, Ciobanu A, et al
    Development of a Human Model for the Study of Effects of Hypoxia, Exercise and Sildenafil on Cardiac and Vascular Function in Chronic Heart Failure.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Abstract available


    January 2015
  24. DING M, Lei J, Qu Y, Zhang H, et al
    Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: